annovisbio.com (ANVS) - Uzoq muddatli majburiyatlarning kapitalga nisbati
Annovis Bio, Inc. (ANVS) kompleks neyrodegeneratsiya terapiyasi tizimini ishlab chiqmoqda, bu esa brendning Altsgeymer kasalligiga qarshi kurashdagi kuchli ilmiy obro'sini ta'kidlaydi. GURU.Markets grafigidagi joriy uzoq muddatli qarzdorlikning kapitalga nisbati 0.00 darajasini ko'rsatmoqda, bu esa biznesning moliyaviy barqarorligini ifodalaydi. Kompaniya hozirda o'zining innovatsion dori vositalari uchun qimmatbaho klinik sinovlarni yakunlash maqsadida mavjud zaxiralaridan rejalashtirilganidek foydalanmoqda.
&width=1200&height=400&colorIndex=0&v=mvx9zauv.4e-7b561vk&start=20220704&end=20261101&filename=GURU_Markets_-_ANVS_-_Annovis-Bio-Inc._-_Long-Term-Debt-to-Equity-Ratio "ANVS - Annovis Bio Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 01.11.2026 oraligʻida | 👁️GURU.Markets👁️")
Annovis Bio, Inc. (ANVS) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi ko'rsatkichlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Annovis Bio, Inc.|ANVS - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati annovisbio.com|ANVS - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Annovis Bio, Inc.|ANVS - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Annovis Bio|Shoshilinch likvidlik annovisbio.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning har tomonlama tahlili:Annovis Bio Inc ANVS
Ushbu koeffitsient bir yildan ortiq muddatli majburiyatlarni umumiy kapitalga nisbatda bog'lab, moliyalashtirish tuzilmasidagi qarz yukining darajasini o'lchaydi. Past qiymatlar moliyaviy barqarorlikni tasdiqlaydi, qimmatning oshishi esa defolt xatarlarini ko'rsatadi. Uzoq muddatli qarzning kapitalga nisbati grafigini tahlil qilish orqali investor biznesning xavfsizlik zaxirasini baholaydi. Bu Annovis Bio, Inc. (ANVS) uchun juda muhimdir, chunki uning nevrologik portfelini ishlab chiqish bozorning oldindan ishonchiga bog'liq. Boshqaruv barqarorligi va minimal qarzning uyg'unligi klinik sinovlarni yakunlash uchun zarur bo'lgan resurslarni ta'minlaydi.
Raqobatdosh kompaniyalar tahlili
Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati NBIX|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Axsome Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acadia-pharm.com ACAD|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Catalyst Corp (CPRX)|DNLI (Denali Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati harmonybiosciences.com|Uzoq muddatli qarzning o'z kapitaliga nisbati Biohaven (BHVN)|Amylyx Pharmaceuticals Inc - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning o'z kapitaliga nisbati Trevi Pharma TRVI|PRAX: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|AVXL - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati ceribell.com|PRTA (Prothena Corp) - Uzoq muddatli qarzning o'z kapitaliga nisbati|ALEC (Alector) - Uzoq muddatli qarzning o'z kapitaliga nisbati|ANNX (Annexon Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Omeros Corp. (OMER) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Neurogene Inc. (NGNE)|Uzoq muddatli qarzdorlikning kapitalga nisbati acimmune.com|Voyager Therapeutics, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti NMRA|Scilex Holding Co. - Uzoq muddatli qarzning kapitalga nisbati|TVGN: Uzoq muddatli qarzning o'z kapitaliga nisbati|ACOG: Uzoq muddatli qarzning kapitalga nisbati|CGTX - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Inhibikase Therapeutics, Inc.|Uzoq muddatli majburiyatlarning kapitalga nisbati Cassava Sciences Inc SAVA|Uzoq muddatli qarzning o'z kapitaliga nisbati ASRT (Assertio Holdings, Inc.)|COYA (coyatherapeutics.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati VTGN (Vistagen)|Uzoq muddatli qarzdorlikning kapitalga nisbati Ovid Therapeutics Inc (OVID)|ABOS - Uzoq muddatli qarzning o'z kapitaliga nisbati|CRVO (CervoMed, Inc.) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|ATHE: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Clene|Uzoq muddatli qarzning o'z kapitaliga nisbati PEPG|jupiterneurosciences.com (JUNS) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati RLMD|Uzoq muddatli qarzning kapitalga nisbati gracetx.com (GRCE)|Uzoq muddatli qarzning o'z kapitaliga nisbati Firefly Neuroscience Inc AIFF|KLTO: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|NRSN: Uzoq muddatli qarzning o'z kapitaliga nisbati|RVPH: Uzoq muddatli qarzning o'z kapitaliga nisbati|metaviatx.com (MTVA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|NRXS - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Helius Medical Technologies, Inc.|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi PASG (Passage Bio Corp)|Uzoq muddatli qarzning kapitalga nisbati NEUP|NERV - Uzoq muddatli majburiyatlarning kapitalga nisbati|Athira Pharma - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati Addex Therapeutics Ltd. ADXN|ALZN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti CYCN (Cyclerion Therapeutics)|protagenic.com (PTIX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Pasithea Therapeutics Corp. (KTTA)|CRGT (Cortigent Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Avenue Therapeutics Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati Brainstorm Cell Therapeutics, Inc. (BCLI)|Cara Therapeutics Inc - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning o'z kapitaliga nisbati Chromocell Therapeutics CHRO|ELYM: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|ITCI - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Longboard Pharmaceuticals Inc|MRNS (Marinus) - Uzoq muddatli qarzning o'z kapitaliga nisbati|NKGN (NKGen Biotech Corp) - Uzoq muddatli qarzning o'z kapitaliga nisbati|NRBO (NeuroBo Pharmaceuticals) - Uzoq muddatli qarzning kapitalga nisbati|sagerx.com (SAGE) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Synaptogenix (SNPX)|Uzoq muddatli qarzdorlikning kapitalga nisbati Trevena Inc.|Vigil Neuroscience, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti WENA|Cerevel Therapeutics - Uzoq muddatli qarzning kapitalga nisbati